After Hours Summary: NVDA +26.8% surges on earnings and especially its huge guidance, which is causing many semi and semi equipment names to rise, AMD +8.9%, TSM +7.9%; NTNX +15.9%, ELF +11.6% also higher on earnings; APPS -26.6%, AEO -17.3%, SNOW -11.2% lower on earningsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: NVDA +26.8%, NTNX +15.9%, ELF +11.6%, ZUO +8.6%, VNET +8.6%, SPLK +7.6%, MOD +4.5%, GES +3.2% (also increases dividend), PLUS +2.5%, RAMP +1.8%, ENS +1.1%
Companies trading higher in after hours in reaction to news: DM +19.5% (SSYS in talks to acquire DM, according to Bloomberg), AMD +8.9% (in sympathy with strong NVDA earnings/guidance), TSM +7.9% (in sympathy with strong NVDA earnings/guidance), ARQT +5.3% (COO to step down), KLIC +3% (in sympathy with strong NVDA earnings/guidance), ACLS +2.8% (in sympathy with strong NVDA earnings/guidance), AVGO +2.1% (in sympathy with strong NVDA earnings/guidance), WSBF +2% (authorizes new 2 mln share repurchase program), MSFT +1.8% (in sympathy with strong NVDA earnings/guidance), FLR +1.6% (awarded contract from Harbour Energy), EQH +1.5% (increases dividend), AMAT +0.8% (in sympathy with strong NVDA earnings/guidance), LRCX +0.7% (in sympathy with strong NVDA earnings/guidance), RKLB +0.6% (preparing for second of two Electron launches), TXG +0.5% (announces commercial availability of a new Visium CytAssist Gene and Protein Expression product), UVV +0.5% (increases dividend), FCPT +0.3% (to acquire up to 14 Darden restaurant properties), INTC +0.3% (in sympathy with strong NVDA earnings/guidance), KLAC +0.3% (in sympathy with strong NVDA earnings/guidance)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: APPS -26.6%, AEO -17.3%, SNOW -11.2%, PATH -8.8%, RRGB -1%
Companies trading lower in after hours in reaction to news: ANNX -22.1% (topline data from ARCHER Phase 2 trial), MRTX -6.6% (SAPPHIRE study did not meet its primary endpoint), MYGN -2% (announces addition of Folate Receptor Alpha to portfolio), SSYS -2% (SSYS in talks to acquire DM, according to Bloomberg), BCLI -1.3% (COO to step down)